47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,2 | 1,5 | 1,7 | 13,2 |
Gross profit (loss) | 1,3 | 1,5 | 1,7 | 13 |
EBITDA | 1,4 | 1,5 | 1,7 | 12,5 |
Short time liabilities | 0,6 | 1,3 | 1,3 | -2,3 |
Other operating costs | 0,1 | 0 | 0 | 11,7 |
Equity capital | 0,7 | 0,5 | 0,7 | 34 |
Operating profit (EBIT) | 1,3 | 1,5 | 1,7 | 13 |
Assets | 1,4 | 1,8 | 2 | 8,4 |
Net profit (loss) | 1,3 | 1,5 | 1,7 | 13 |
Cash | 0,2 | 0,4 | 0,3 | -30,7 |
Liabilities and provisions for liabilities | 0,7 | 1,3 | 1,3 | -2,2 |
Net income from sale | 11 | 12,7 | 13,6 | 6,6 |
Working assets | 1,2 | 1,7 | 1,9 | 10,4 |
Other income costs | 0,2 | 0 | 0 | 3,8 |
Depreciation | 0 | 0 | 0 | -12,9 |
% | % | % | p.p. | |
Profitability of capital | 198,2 | 276 | 232,7 | -43,3 |
Equity capital to total assets | 49 | 29,3 | 36,2 | 6,9 |
Gross profit margin | 12 | 11,7 | 12,4 | 0,7 |
EBITDA Margin | 12,3 | 11,9 | 12,6 | 0,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 21 | 37 | 34 | -3 |
Current financial liquidity indicator | 1.956217885017395 | 1.345292568206787 | 1.5195194482803345 | 0,2 |
Net dept to EBITDA | -0.013474232517182827 | -0.23057015240192413 | -0.1661558300256729 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane